Group 1:Recombinant Human Serum Albumin

2 trials

Sponsors

Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences Peking Union Medical College Hospital

Conditions

hepatic ascites

Phase 1

A randomized, double-blind, single-dose, dose-escalation phase Ia clinical study to evaluate the safety, tolerability and pharmacokinetics of recombinant human serum albumin in healthy subjects

RecruitingChiCTR2100053832

Beijing Union Medical College Hospitalhepatic ascites

Start: 2021-01-01Updated: 2022-10-24

A randomized, double-blind, active drug-controlled, dose-escalation phase Ib clinical study to evaluate the safety, tolerability, pharmacokinetics, and preliminary efficacy of recombinant human serum albumin in patients with cirrhosis and ascites

RecruitingChiCTR2100053877

Chinese Academy of Medical Sciences Peking Union Medical College Hospitalhepatic ascites

Start: 2021-10-01Updated: 2022-10-31